nodes	percent_of_prediction	percent_of_DWPC	metapath
Difluprednate—NR3C1—hematologic cancer	0.161	1	CbGaD
Difluprednate—Dexamethasone—hematologic cancer	0.116	0.336	CrCtD
Difluprednate—Betamethasone—hematologic cancer	0.116	0.336	CrCtD
Difluprednate—Triamcinolone—hematologic cancer	0.114	0.328	CrCtD
Difluprednate—NR3C1—Triamcinolone—hematologic cancer	0.0356	0.25	CbGbCtD
Difluprednate—NR3C1—Betamethasone—hematologic cancer	0.0306	0.214	CbGbCtD
Difluprednate—NR3C1—Prednisolone—hematologic cancer	0.0301	0.211	CbGbCtD
Difluprednate—NR3C1—Prednisone—hematologic cancer	0.0285	0.2	CbGbCtD
Difluprednate—NR3C1—Dexamethasone—hematologic cancer	0.0178	0.125	CbGbCtD
Difluprednate—Fluticasone furoate—Betamethasone—hematologic cancer	0.00368	0.0137	CrCrCtD
Difluprednate—Fluticasone furoate—Dexamethasone—hematologic cancer	0.00368	0.0137	CrCrCtD
Difluprednate—Fluticasone furoate—Triamcinolone—hematologic cancer	0.0036	0.0134	CrCrCtD
Difluprednate—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00331	0.0123	CrCrCtD
Difluprednate—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00331	0.0123	CrCrCtD
Difluprednate—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00323	0.0121	CrCrCtD
Difluprednate—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.0032	0.012	CrCrCtD
Difluprednate—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.0032	0.012	CrCrCtD
Difluprednate—Halobetasol Propionate—Betamethasone—hematologic cancer	0.0032	0.012	CrCrCtD
Difluprednate—Fluticasone Propionate—Betamethasone—hematologic cancer	0.0032	0.012	CrCrCtD
Difluprednate—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00313	0.0117	CrCrCtD
Difluprednate—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00313	0.0117	CrCrCtD
Difluprednate—Fluocinonide—Betamethasone—hematologic cancer	0.00301	0.0112	CrCrCtD
Difluprednate—Prednicarbate—Betamethasone—hematologic cancer	0.00301	0.0112	CrCrCtD
Difluprednate—Fluocinonide—Dexamethasone—hematologic cancer	0.00301	0.0112	CrCrCtD
Difluprednate—Prednicarbate—Dexamethasone—hematologic cancer	0.00301	0.0112	CrCrCtD
Difluprednate—Clocortolone—Betamethasone—hematologic cancer	0.00301	0.0112	CrCrCtD
Difluprednate—Beclomethasone—Dexamethasone—hematologic cancer	0.00301	0.0112	CrCrCtD
Difluprednate—Clocortolone—Dexamethasone—hematologic cancer	0.00301	0.0112	CrCrCtD
Difluprednate—Beclomethasone—Betamethasone—hematologic cancer	0.00301	0.0112	CrCrCtD
Difluprednate—Clocortolone—Triamcinolone—hematologic cancer	0.00294	0.011	CrCrCtD
Difluprednate—Prednicarbate—Triamcinolone—hematologic cancer	0.00294	0.011	CrCrCtD
Difluprednate—Fluocinonide—Triamcinolone—hematologic cancer	0.00294	0.011	CrCrCtD
Difluprednate—Beclomethasone—Triamcinolone—hematologic cancer	0.00294	0.011	CrCrCtD
Difluprednate—Cortisone acetate—Prednisone—hematologic cancer	0.00288	0.0107	CrCrCtD
Difluprednate—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00284	0.0106	CrCrCtD
Difluprednate—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00284	0.0106	CrCrCtD
Difluprednate—Cortisone acetate—Prednisolone—hematologic cancer	0.00281	0.0105	CrCrCtD
Difluprednate—Prednicarbate—Prednisone—hematologic cancer	0.00279	0.0104	CrCrCtD
Difluprednate—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00278	0.0104	CrCrCtD
Difluprednate—Amcinonide—Dexamethasone—hematologic cancer	0.00277	0.0103	CrCrCtD
Difluprednate—Amcinonide—Betamethasone—hematologic cancer	0.00277	0.0103	CrCrCtD
Difluprednate—Prednicarbate—Prednisolone—hematologic cancer	0.00272	0.0102	CrCrCtD
Difluprednate—Clocortolone—Prednisolone—hematologic cancer	0.00272	0.0102	CrCrCtD
Difluprednate—Beclomethasone—Prednisolone—hematologic cancer	0.00272	0.0102	CrCrCtD
Difluprednate—Amcinonide—Triamcinolone—hematologic cancer	0.0027	0.0101	CrCrCtD
Difluprednate—Diflorasone—Betamethasone—hematologic cancer	0.0027	0.0101	CrCrCtD
Difluprednate—Flunisolide—Betamethasone—hematologic cancer	0.0027	0.0101	CrCrCtD
Difluprednate—Clobetasol propionate—Dexamethasone—hematologic cancer	0.0027	0.0101	CrCrCtD
Difluprednate—Clobetasol propionate—Betamethasone—hematologic cancer	0.0027	0.0101	CrCrCtD
Difluprednate—Flunisolide—Dexamethasone—hematologic cancer	0.0027	0.0101	CrCrCtD
Difluprednate—Diflorasone—Dexamethasone—hematologic cancer	0.0027	0.0101	CrCrCtD
Difluprednate—Diflorasone—Triamcinolone—hematologic cancer	0.00263	0.00983	CrCrCtD
Difluprednate—Flunisolide—Triamcinolone—hematologic cancer	0.00263	0.00983	CrCrCtD
Difluprednate—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00263	0.00983	CrCrCtD
Difluprednate—Paramethasone—Betamethasone—hematologic cancer	0.00263	0.00981	CrCrCtD
Difluprednate—Paramethasone—Dexamethasone—hematologic cancer	0.00263	0.00981	CrCrCtD
Difluprednate—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00257	0.00961	CrCrCtD
Difluprednate—Paramethasone—Triamcinolone—hematologic cancer	0.00257	0.00958	CrCrCtD
Difluprednate—Amcinonide—Prednisone—hematologic cancer	0.00257	0.00958	CrCrCtD
Difluprednate—Desoximetasone—Betamethasone—hematologic cancer	0.00256	0.00957	CrCrCtD
Difluprednate—Desoximetasone—Dexamethasone—hematologic cancer	0.00256	0.00957	CrCrCtD
Difluprednate—Desoximetasone—Triamcinolone—hematologic cancer	0.00251	0.00935	CrCrCtD
Difluprednate—Amcinonide—Prednisolone—hematologic cancer	0.0025	0.00935	CrCrCtD
Difluprednate—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.0025	0.00934	CrCrCtD
Difluprednate—Fluorometholone—Dexamethasone—hematologic cancer	0.0025	0.00934	CrCrCtD
Difluprednate—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.0025	0.00934	CrCrCtD
Difluprednate—Mometasone—Betamethasone—hematologic cancer	0.0025	0.00934	CrCrCtD
Difluprednate—Triamcinolone—Dexamethasone—hematologic cancer	0.0025	0.00934	CrCrCtD
Difluprednate—Triamcinolone—Betamethasone—hematologic cancer	0.0025	0.00934	CrCrCtD
Difluprednate—Mometasone—Dexamethasone—hematologic cancer	0.0025	0.00934	CrCrCtD
Difluprednate—Fluorometholone—Betamethasone—hematologic cancer	0.0025	0.00934	CrCrCtD
Difluprednate—Flunisolide—Prednisone—hematologic cancer	0.0025	0.00933	CrCrCtD
Difluprednate—Clobetasol propionate—Prednisone—hematologic cancer	0.0025	0.00933	CrCrCtD
Difluprednate—Diflorasone—Prednisone—hematologic cancer	0.0025	0.00933	CrCrCtD
Difluprednate—Betamethasone—Dexamethasone—hematologic cancer	0.00245	0.00913	CrCrCtD
Difluprednate—Dexamethasone—Betamethasone—hematologic cancer	0.00245	0.00913	CrCrCtD
Difluprednate—Rimexolone—Betamethasone—hematologic cancer	0.00245	0.00913	CrCrCtD
Difluprednate—Rimexolone—Dexamethasone—hematologic cancer	0.00245	0.00913	CrCrCtD
Difluprednate—Mometasone—Triamcinolone—hematologic cancer	0.00245	0.00913	CrCrCtD
Difluprednate—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00245	0.00913	CrCrCtD
Difluprednate—Fluorometholone—Triamcinolone—hematologic cancer	0.00245	0.00913	CrCrCtD
Difluprednate—Flunisolide—Prednisolone—hematologic cancer	0.00244	0.00911	CrCrCtD
Difluprednate—Diflorasone—Prednisolone—hematologic cancer	0.00244	0.00911	CrCrCtD
Difluprednate—Clobetasol propionate—Prednisolone—hematologic cancer	0.00244	0.00911	CrCrCtD
Difluprednate—Paramethasone—Prednisone—hematologic cancer	0.00244	0.0091	CrCrCtD
Difluprednate—Rimexolone—Triamcinolone—hematologic cancer	0.00239	0.00892	CrCrCtD
Difluprednate—Betamethasone—Triamcinolone—hematologic cancer	0.00239	0.00892	CrCrCtD
Difluprednate—Dexamethasone—Triamcinolone—hematologic cancer	0.00239	0.00892	CrCrCtD
Difluprednate—Paramethasone—Prednisolone—hematologic cancer	0.00238	0.00888	CrCrCtD
Difluprednate—Desoximetasone—Prednisone—hematologic cancer	0.00238	0.00887	CrCrCtD
Difluprednate—Methylprednisolone—Betamethasone—hematologic cancer	0.00234	0.00873	CrCrCtD
Difluprednate—Methylprednisolone—Dexamethasone—hematologic cancer	0.00234	0.00873	CrCrCtD
Difluprednate—Triamcinolone—Prednisone—hematologic cancer	0.00232	0.00866	CrCrCtD
Difluprednate—Mometasone—Prednisone—hematologic cancer	0.00232	0.00866	CrCrCtD
Difluprednate—Fluorometholone—Prednisone—hematologic cancer	0.00232	0.00866	CrCrCtD
Difluprednate—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00232	0.00866	CrCrCtD
Difluprednate—Desoximetasone—Prednisolone—hematologic cancer	0.00232	0.00866	CrCrCtD
Difluprednate—Methylprednisolone—Triamcinolone—hematologic cancer	0.00229	0.00853	CrCrCtD
Difluprednate—Dexamethasone—Prednisone—hematologic cancer	0.00227	0.00847	CrCrCtD
Difluprednate—Rimexolone—Prednisone—hematologic cancer	0.00227	0.00847	CrCrCtD
Difluprednate—Betamethasone—Prednisone—hematologic cancer	0.00227	0.00847	CrCrCtD
Difluprednate—Triamcinolone—Prednisolone—hematologic cancer	0.00227	0.00846	CrCrCtD
Difluprednate—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00227	0.00846	CrCrCtD
Difluprednate—Fluorometholone—Prednisolone—hematologic cancer	0.00227	0.00846	CrCrCtD
Difluprednate—Mometasone—Prednisolone—hematologic cancer	0.00227	0.00846	CrCrCtD
Difluprednate—Dexamethasone—Prednisolone—hematologic cancer	0.00221	0.00826	CrCrCtD
Difluprednate—Betamethasone—Prednisolone—hematologic cancer	0.00221	0.00826	CrCrCtD
Difluprednate—Rimexolone—Prednisolone—hematologic cancer	0.00221	0.00826	CrCrCtD
Difluprednate—Methylprednisolone—Prednisone—hematologic cancer	0.00217	0.0081	CrCrCtD
Difluprednate—Methylprednisolone—Prednisolone—hematologic cancer	0.00212	0.0079	CrCrCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—RFXANK—hematologic cancer	0.00106	0.0406	CbGpPWpGaD
Difluprednate—Conjunctival oedema—Dasatinib—hematologic cancer	0.000852	0.0157	CcSEcCtD
Difluprednate—Uveitis—Pentostatin—hematologic cancer	0.000819	0.015	CcSEcCtD
Difluprednate—Teratogenicity—Thalidomide—hematologic cancer	0.00075	0.0138	CcSEcCtD
Difluprednate—Posterior subcapsular cataract—Prednisolone—hematologic cancer	0.000744	0.0137	CcSEcCtD
Difluprednate—Hyperaemia—Nilotinib—hematologic cancer	0.000724	0.0133	CcSEcCtD
Difluprednate—Teratogenicity—Carmustine—hematologic cancer	0.00072	0.0132	CcSEcCtD
Difluprednate—Panophthalmitis—Bortezomib—hematologic cancer	0.000714	0.0131	CcSEcCtD
Difluprednate—Teratogenicity—Alitretinoin—hematologic cancer	0.000714	0.0131	CcSEcCtD
Difluprednate—Corneal thinning—Betamethasone—hematologic cancer	0.00071	0.013	CcSEcCtD
Difluprednate—Corneal thinning—Dexamethasone—hematologic cancer	0.00071	0.013	CcSEcCtD
Difluprednate—Iridocyclitis—Prednisolone—hematologic cancer	0.000701	0.0129	CcSEcCtD
Difluprednate—Posterior subcapsular cataract—Betamethasone—hematologic cancer	0.000621	0.0114	CcSEcCtD
Difluprednate—Posterior subcapsular cataract—Dexamethasone—hematologic cancer	0.000621	0.0114	CcSEcCtD
Difluprednate—Hyperaemia—Bortezomib—hematologic cancer	0.000577	0.0106	CcSEcCtD
Difluprednate—Skin striae—Bleomycin—hematologic cancer	0.000544	0.01	CcSEcCtD
Difluprednate—Conjunctival oedema—Carmustine—hematologic cancer	0.000544	0.01	CcSEcCtD
Difluprednate—Sensation of foreign body—Bortezomib—hematologic cancer	0.000535	0.00983	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY1—hematologic cancer	0.000529	0.0202	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY2—hematologic cancer	0.000529	0.0202	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER2—hematologic cancer	0.000529	0.0202	CbGpPWpGaD
Difluprednate—Nerve injury—Prednisolone—hematologic cancer	0.000527	0.00969	CcSEcCtD
Difluprednate—Hyperaemia—Carmustine—hematologic cancer	0.0005	0.00919	CcSEcCtD
Difluprednate—Skin striae—Alitretinoin—hematologic cancer	0.00047	0.00864	CcSEcCtD
Difluprednate—Scab—Alitretinoin—hematologic cancer	0.00047	0.00864	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—hematologic cancer	0.000461	0.0176	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—CEBPD—hematologic cancer	0.000461	0.0176	CbGpPWpGaD
Difluprednate—Corneal oedema—Betamethasone—hematologic cancer	0.000458	0.00843	CcSEcCtD
Difluprednate—Corneal oedema—Dexamethasone—hematologic cancer	0.000458	0.00843	CcSEcCtD
Difluprednate—Cataract subcapsular—Prednisolone—hematologic cancer	0.000441	0.00811	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—HDAC11—hematologic cancer	0.00044	0.0169	CbGpPWpGaD
Difluprednate—Nerve injury—Dexamethasone—hematologic cancer	0.00044	0.00809	CcSEcCtD
Difluprednate—Nerve injury—Betamethasone—hematologic cancer	0.00044	0.00809	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—GATA2—hematologic cancer	0.000407	0.0156	CbGpPWpGaD
Difluprednate—Cataract subcapsular—Triamcinolone—hematologic cancer	0.000406	0.00746	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER1—hematologic cancer	0.000401	0.0153	CbGpPWpGaD
Difluprednate—Visual acuity reduced—Dasatinib—hematologic cancer	0.000398	0.00731	CcSEcCtD
Difluprednate—Panophthalmitis—Dexamethasone—hematologic cancer	0.000393	0.00723	CcSEcCtD
Difluprednate—Panophthalmitis—Betamethasone—hematologic cancer	0.000393	0.00723	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—HDAC10—hematologic cancer	0.000393	0.015	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—CRY2—hematologic cancer	0.000385	0.0147	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—PER2—hematologic cancer	0.000385	0.0147	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—CRY1—hematologic cancer	0.000385	0.0147	CbGpPWpGaD
Difluprednate—Blepharitis—Bexarotene—hematologic cancer	0.000384	0.00707	CcSEcCtD
Difluprednate—Nerve injury—Prednisone—hematologic cancer	0.000383	0.00704	CcSEcCtD
Difluprednate—Eye infection—Prednisolone—hematologic cancer	0.000371	0.00683	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—BCL6—hematologic cancer	0.000369	0.0141	CbGpPWpGaD
Difluprednate—Cataract subcapsular—Dexamethasone—hematologic cancer	0.000368	0.00677	CcSEcCtD
Difluprednate—Cataract subcapsular—Betamethasone—hematologic cancer	0.000368	0.00677	CcSEcCtD
Difluprednate—Visual acuity reduced—Nilotinib—hematologic cancer	0.000367	0.00675	CcSEcCtD
Difluprednate—Endophthalmitis—Bortezomib—hematologic cancer	0.000366	0.00673	CcSEcCtD
Difluprednate—Skin striae—Prednisolone—hematologic cancer	0.000362	0.00665	CcSEcCtD
Difluprednate—Blepharitis—Nilotinib—hematologic cancer	0.000355	0.00653	CcSEcCtD
Difluprednate—Sensation of foreign body—Prednisolone—hematologic cancer	0.000353	0.00649	CcSEcCtD
Difluprednate—Blepharitis—Imatinib—hematologic cancer	0.000353	0.00649	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—GATA1—hematologic cancer	0.00035	0.0134	CbGpPWpGaD
Difluprednate—Blepharitis—Cladribine—hematologic cancer	0.000347	0.00638	CcSEcCtD
Difluprednate—Conjunctival oedema—Dexamethasone—hematologic cancer	0.000346	0.00636	CcSEcCtD
Difluprednate—Conjunctival oedema—Betamethasone—hematologic cancer	0.000346	0.00636	CcSEcCtD
Difluprednate—Panophthalmitis—Prednisone—hematologic cancer	0.000343	0.0063	CcSEcCtD
Difluprednate—Skin striae—Triamcinolone—hematologic cancer	0.000333	0.00612	CcSEcCtD
Difluprednate—Weight increased—Tioguanine—hematologic cancer	0.000329	0.00605	CcSEcCtD
Difluprednate—Herpes simplex—Methoxsalen—hematologic cancer	0.000325	0.00598	CcSEcCtD
Difluprednate—Cataract subcapsular—Prednisone—hematologic cancer	0.000321	0.00589	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—RARA—hematologic cancer	0.00032	0.0122	CbGpPWpGaD
Difluprednate—Visual acuity reduced—Lenalidomide—hematologic cancer	0.000318	0.00585	CcSEcCtD
Difluprednate—Hyperaemia—Dexamethasone—hematologic cancer	0.000318	0.00585	CcSEcCtD
Difluprednate—Hyperaemia—Betamethasone—hematologic cancer	0.000318	0.00585	CcSEcCtD
Difluprednate—Endophthalmitis—Alitretinoin—hematologic cancer	0.000314	0.00577	CcSEcCtD
Difluprednate—Herpes simplex—Clofarabine—hematologic cancer	0.000312	0.00573	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—GATA2—hematologic cancer	0.000312	0.0119	CbGpPWpGaD
Difluprednate—Lacrimation increased—Pentostatin—hematologic cancer	0.00031	0.00571	CcSEcCtD
Difluprednate—Herpes simplex—Pentostatin—hematologic cancer	0.00031	0.00571	CcSEcCtD
Difluprednate—Eye infection—Dexamethasone—hematologic cancer	0.00031	0.0057	CcSEcCtD
Difluprednate—Eye infection—Betamethasone—hematologic cancer	0.00031	0.0057	CcSEcCtD
Difluprednate—Blepharitis—Hydroxyurea—hematologic cancer	0.000304	0.00558	CcSEcCtD
Difluprednate—Skin striae—Dexamethasone—hematologic cancer	0.000302	0.00555	CcSEcCtD
Difluprednate—Skin striae—Betamethasone—hematologic cancer	0.000302	0.00555	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—PBX1—hematologic cancer	0.000301	0.0115	CbGpPWpGaD
Difluprednate—Sensation of foreign body—Betamethasone—hematologic cancer	0.000295	0.00542	CcSEcCtD
Difluprednate—Sensation of foreign body—Dexamethasone—hematologic cancer	0.000295	0.00542	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—PER1—hematologic cancer	0.000292	0.0112	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—DUSP5—hematologic cancer	0.00029	0.0111	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—hematologic cancer	0.000288	0.011	CbGpPWpGaD
Difluprednate—Weight increased—Ruxolitinib—hematologic cancer	0.000286	0.00526	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—ARNTL—hematologic cancer	0.000286	0.0109	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CBFB—hematologic cancer	0.000283	0.0108	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MAF—hematologic cancer	0.000283	0.0108	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—NCOR2—hematologic cancer	0.000269	0.0103	CbGpPWpGaD
Difluprednate—Photophobia—Pentostatin—hematologic cancer	0.000269	0.00494	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPD—hematologic cancer	0.000265	0.0101	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—hematologic cancer	0.000265	0.0101	CbGpPWpGaD
Difluprednate—Dry eye—Pentostatin—hematologic cancer	0.000264	0.00486	CcSEcCtD
Difluprednate—Pregnancy—Alitretinoin—hematologic cancer	0.000264	0.00484	CcSEcCtD
Difluprednate—Skin striae—Prednisone—hematologic cancer	0.000263	0.00484	CcSEcCtD
Difluprednate—Conjunctival hyperaemia—Prednisolone—hematologic cancer	0.000262	0.00481	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.00026	0.00994	CbGpPWpGaD
Difluprednate—Herpes simplex—Bexarotene—hematologic cancer	0.000257	0.00472	CcSEcCtD
Difluprednate—Eye irritation—Nilotinib—hematologic cancer	0.000256	0.0047	CcSEcCtD
Difluprednate—Eye irritation—Imatinib—hematologic cancer	0.000254	0.00468	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—SUMO1—hematologic cancer	0.000253	0.00968	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—RARA—hematologic cancer	0.000253	0.00968	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CBFB—hematologic cancer	0.000252	0.00964	CbGpPWpGaD
Difluprednate—Visual acuity reduced—Alitretinoin—hematologic cancer	0.000251	0.00462	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—SPI1—hematologic cancer	0.00025	0.00955	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—GATA2—hematologic cancer	0.000249	0.00954	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—EOMES—hematologic cancer	0.000246	0.00943	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—hematologic cancer	0.000245	0.00938	CbGpPWpGaD
Difluprednate—Blepharitis—Alitretinoin—hematologic cancer	0.000243	0.00447	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—TCF3—hematologic cancer	0.00024	0.0092	CbGpPWpGaD
Difluprednate—Herpes simplex—Nilotinib—hematologic cancer	0.000237	0.00436	CcSEcCtD
Difluprednate—Lacrimation increased—Imatinib—hematologic cancer	0.000236	0.00433	CcSEcCtD
Difluprednate—Herpes simplex—Imatinib—hematologic cancer	0.000236	0.00433	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—NR0B2—hematologic cancer	0.000235	0.009	CbGpPWpGaD
Difluprednate—Eye pain—Daunorubicin—hematologic cancer	0.000231	0.00425	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—CEBPA—hematologic cancer	0.000228	0.00872	CbGpPWpGaD
Difluprednate—Photophobia—Procarbazine—hematologic cancer	0.000227	0.00416	CcSEcCtD
Difluprednate—Eye irritation—Lenalidomide—hematologic cancer	0.000222	0.00408	CcSEcCtD
Difluprednate—Dry eye—Bexarotene—hematologic cancer	0.000218	0.00402	CcSEcCtD
Difluprednate—Dry eye—Dasatinib—hematologic cancer	0.000218	0.00402	CcSEcCtD
Difluprednate—Conjunctival hyperaemia—Dexamethasone—hematologic cancer	0.000218	0.00401	CcSEcCtD
Difluprednate—Conjunctival hyperaemia—Betamethasone—hematologic cancer	0.000218	0.00401	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—hematologic cancer	0.000216	0.00825	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—NUP214—hematologic cancer	0.000211	0.00805	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—ARNTL—hematologic cancer	0.000208	0.00796	CbGpPWpGaD
Difluprednate—Herpes simplex—Lenalidomide—hematologic cancer	0.000205	0.00378	CcSEcCtD
Difluprednate—Photophobia—Nilotinib—hematologic cancer	0.000205	0.00377	CcSEcCtD
Difluprednate—Eye irritation—Bortezomib—hematologic cancer	0.000204	0.00375	CcSEcCtD
Difluprednate—Dry eye—Nilotinib—hematologic cancer	0.000202	0.00371	CcSEcCtD
Difluprednate—Endophthalmitis—Betamethasone—hematologic cancer	0.000202	0.00371	CcSEcCtD
Difluprednate—Endophthalmitis—Dexamethasone—hematologic cancer	0.000202	0.00371	CcSEcCtD
Difluprednate—Dry eye—Imatinib—hematologic cancer	0.000201	0.00369	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—EBF1—hematologic cancer	0.000194	0.00741	CbGpPWpGaD
Difluprednate—Photophobia—Vinblastine—hematologic cancer	0.000192	0.00353	CcSEcCtD
Difluprednate—Eye pain—Bexarotene—hematologic cancer	0.00019	0.0035	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—LEF1—hematologic cancer	0.00019	0.00727	CbGpPWpGaD
Difluprednate—Herpes simplex—Bortezomib—hematologic cancer	0.000189	0.00348	CcSEcCtD
Difluprednate—Lacrimation increased—Bortezomib—hematologic cancer	0.000189	0.00348	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—hematologic cancer	0.000189	0.00721	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.00018	0.00689	CbGpPWpGaD
Difluprednate—Endophthalmitis—Prednisone—hematologic cancer	0.000176	0.00323	CcSEcCtD
Difluprednate—Eye pain—Nilotinib—hematologic cancer	0.000176	0.00323	CcSEcCtD
Difluprednate—Eye irritation—Alitretinoin—hematologic cancer	0.000175	0.00322	CcSEcCtD
Difluprednate—Dry eye—Lenalidomide—hematologic cancer	0.000175	0.00322	CcSEcCtD
Difluprednate—Eye pain—Imatinib—hematologic cancer	0.000175	0.00321	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—hematologic cancer	0.000175	0.00668	CbGpPWpGaD
Difluprednate—Eye irritation—Ifosfamide—hematologic cancer	0.000173	0.00318	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hematologic cancer	0.000173	0.00662	CbGpPWpGaD
Difluprednate—Herpes simplex—Thalidomide—hematologic cancer	0.000171	0.00313	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—REL—hematologic cancer	0.000167	0.0064	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—ID3—hematologic cancer	0.000165	0.0063	CbGpPWpGaD
Difluprednate—Photophobia—Bortezomib—hematologic cancer	0.000164	0.00301	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—hematologic cancer	0.000163	0.00625	CbGpPWpGaD
Difluprednate—Weight increased—Anagrelide—hematologic cancer	0.000163	0.003	CcSEcCtD
Difluprednate—Lacrimation increased—Alitretinoin—hematologic cancer	0.000162	0.00298	CcSEcCtD
Difluprednate—Herpes simplex—Alitretinoin—hematologic cancer	0.000162	0.00298	CcSEcCtD
Difluprednate—Visual acuity reduced—Dexamethasone—hematologic cancer	0.000162	0.00297	CcSEcCtD
Difluprednate—Visual acuity reduced—Betamethasone—hematologic cancer	0.000162	0.00297	CcSEcCtD
Difluprednate—Dry eye—Bortezomib—hematologic cancer	0.000161	0.00296	CcSEcCtD
Difluprednate—Blepharitis—Dexamethasone—hematologic cancer	0.000156	0.00287	CcSEcCtD
Difluprednate—Blepharitis—Betamethasone—hematologic cancer	0.000156	0.00287	CcSEcCtD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—hematologic cancer	0.000154	0.00588	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—hematologic cancer	0.000153	0.00586	CbGpPWpGaD
Difluprednate—Photophobia—Thiotepa—hematologic cancer	0.000153	0.0028	CcSEcCtD
Difluprednate—Lacrimation increased—Irinotecan—hematologic cancer	0.000152	0.0028	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—GATA2—hematologic cancer	0.000152	0.00581	CbGpPWpGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—hematologic cancer	0.000152	0.00581	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—JUND—hematologic cancer	0.000146	0.00558	CbGpPWpGaD
Difluprednate—Dry eye—Thalidomide—hematologic cancer	0.000145	0.00267	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—MYB—hematologic cancer	0.000143	0.00548	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—AR—hematologic cancer	0.000143	0.00547	CbGpPWpGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—hematologic cancer	0.000143	0.00547	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TCF3—hematologic cancer	0.000142	0.00545	CbGpPWpGaD
Difluprednate—Weight increased—Busulfan—hematologic cancer	0.000142	0.00261	CcSEcCtD
Difluprednate—Photophobia—Alitretinoin—hematologic cancer	0.00014	0.00258	CcSEcCtD
Difluprednate—Eye pain—Bortezomib—hematologic cancer	0.00014	0.00258	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—DKK1—hematologic cancer	0.000138	0.00529	CbGpPWpGaD
Difluprednate—Dry eye—Alitretinoin—hematologic cancer	0.000138	0.00254	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—hematologic cancer	0.000138	0.00528	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—CREB1—hematologic cancer	0.000137	0.00523	CbGpPWpGaD
Difluprednate—Weight increased—Bexarotene—hematologic cancer	0.000135	0.00248	CcSEcCtD
Difluprednate—Weight increased—Dasatinib—hematologic cancer	0.000135	0.00248	CcSEcCtD
Difluprednate—Eye irritation—Prednisolone—hematologic cancer	0.000135	0.00248	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GATA2—hematologic cancer	0.000131	0.00503	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—hematologic cancer	0.000128	0.00488	CbGpPWpGaD
Difluprednate—Pruritus—Ruxolitinib—hematologic cancer	0.000127	0.00233	CcSEcCtD
Difluprednate—Vision blurred—Nelarabine—hematologic cancer	0.000126	0.00232	CcSEcCtD
Difluprednate—Eye pain—Thalidomide—hematologic cancer	0.000126	0.00232	CcSEcCtD
Difluprednate—Herpes simplex—Prednisolone—hematologic cancer	0.000125	0.0023	CcSEcCtD
Difluprednate—Weight increased—Nilotinib—hematologic cancer	0.000125	0.00229	CcSEcCtD
Difluprednate—Weight increased—Imatinib—hematologic cancer	0.000124	0.00228	CcSEcCtD
Difluprednate—Eye pain—Carmustine—hematologic cancer	0.000121	0.00223	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—PTHLH—hematologic cancer	0.00012	0.00461	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—RARA—hematologic cancer	0.00012	0.00458	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—STAT5B—hematologic cancer	0.000118	0.00452	CbGpPWpGaD
Difluprednate—Vision blurred—Anagrelide—hematologic cancer	0.000118	0.00217	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—hematologic cancer	0.000117	0.00449	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—RET—hematologic cancer	0.000116	0.00444	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—AR—hematologic cancer	0.000113	0.00432	CbGpPWpGaD
Difluprednate—Headache—Ruxolitinib—hematologic cancer	0.000112	0.00206	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—CEBPA—hematologic cancer	0.000111	0.00426	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—CEBPD—hematologic cancer	0.000111	0.00426	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ZNF552—hematologic cancer	0.00011	0.0042	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—EZH2—hematologic cancer	0.00011	0.00419	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—AR—hematologic cancer	0.00011	0.00419	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—hematologic cancer	0.000109	0.00416	CbGpPWpGaD
Difluprednate—Weight increased—Lenalidomide—hematologic cancer	0.000108	0.00199	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL13—hematologic cancer	0.000108	0.00413	CbGpPWpGaD
Difluprednate—Pruritus—Vorinostat—hematologic cancer	0.000107	0.00197	CcSEcCtD
Difluprednate—Weight increased—Hydroxyurea—hematologic cancer	0.000107	0.00196	CcSEcCtD
Difluprednate—Herpes simplex—Dexamethasone—hematologic cancer	0.000104	0.00192	CcSEcCtD
Difluprednate—Herpes simplex—Betamethasone—hematologic cancer	0.000104	0.00192	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—NCOR2—hematologic cancer	0.0001	0.00384	CbGpPWpGaD
Difluprednate—Weight increased—Bortezomib—hematologic cancer	9.95e-05	0.00183	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	9.84e-05	0.00376	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—hematologic cancer	9.82e-05	0.00376	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—ESR1—hematologic cancer	9.82e-05	0.00376	CbGpPWpGaD
Difluprednate—Vision blurred—Dasatinib—hematologic cancer	9.74e-05	0.00179	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—GATA3—hematologic cancer	9.74e-05	0.00373	CbGpPWpGaD
Difluprednate—Headache—Vorinostat—hematologic cancer	9.47e-05	0.00174	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	9.33e-05	0.00357	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hematologic cancer	9.31e-05	0.00356	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—NCOR1—hematologic cancer	9.3e-05	0.00356	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—STAT1—hematologic cancer	9.28e-05	0.00355	CbGpPWpGaD
Difluprednate—Weight increased—Thiotepa—hematologic cancer	9.28e-05	0.00171	CcSEcCtD
Difluprednate—Pruritus—Mechlorethamine—hematologic cancer	9.19e-05	0.00169	CcSEcCtD
Difluprednate—Prednicarbate—NR3C1—hematologic cancer	9.16e-05	0.0564	CrCbGaD
Difluprednate—Clocortolone—NR3C1—hematologic cancer	9.16e-05	0.0564	CrCbGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—hematologic cancer	9.14e-05	0.0035	CbGpPWpGaD
Difluprednate—Vision blurred—Nilotinib—hematologic cancer	9e-05	0.00165	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	9e-05	0.00344	CbGpPWpGaD
Difluprednate—Weight increased—Thalidomide—hematologic cancer	8.97e-05	0.00165	CcSEcCtD
Difluprednate—Vision blurred—Imatinib—hematologic cancer	8.95e-05	0.00165	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	8.91e-05	0.00341	CbGpPWpGaD
Difluprednate—Dry eye—Betamethasone—hematologic cancer	8.87e-05	0.00163	CcSEcCtD
Difluprednate—Dry eye—Dexamethasone—hematologic cancer	8.87e-05	0.00163	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	8.79e-05	0.00336	CbGpPWpGaD
Difluprednate—Diflorasone—NR3C1—hematologic cancer	8.67e-05	0.0534	CrCbGaD
Difluprednate—Weight increased—Alitretinoin—hematologic cancer	8.54e-05	0.00157	CcSEcCtD
Difluprednate—Desoximetasone—NR3C1—hematologic cancer	8.45e-05	0.052	CrCbGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	8.28e-05	0.00317	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	8.17e-05	0.00313	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—STAT5B—hematologic cancer	8.16e-05	0.00312	CbGpPWpGaD
Difluprednate—Weight increased—Mitoxantrone—hematologic cancer	8.01e-05	0.00147	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	7.99e-05	0.00306	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	7.92e-05	0.00303	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	7.85e-05	0.00301	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	7.84e-05	0.003	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	7.8e-05	0.00299	CbGpPWpGaD
Difluprednate—Vision blurred—Lenalidomide—hematologic cancer	7.8e-05	0.00143	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	7.76e-05	0.00297	CbGpPWpGaD
Difluprednate—Eye pain—Dexamethasone—hematologic cancer	7.72e-05	0.00142	CcSEcCtD
Difluprednate—Eye pain—Betamethasone—hematologic cancer	7.72e-05	0.00142	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	7.67e-05	0.00293	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	7.66e-05	0.00293	CbGpPWpGaD
Difluprednate—Herpes simplex—Methotrexate—hematologic cancer	7.59e-05	0.00139	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	7.58e-05	0.0029	CbGpPWpGaD
Difluprednate—Pruritus—Methoxsalen—hematologic cancer	7.57e-05	0.00139	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	7.54e-05	0.00289	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	7.46e-05	0.00285	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	7.36e-05	0.00282	CbGpPWpGaD
Difluprednate—Flumethasone Pivalate—NR3C1—hematologic cancer	7.28e-05	0.0448	CrCbGaD
Difluprednate—Pruritus—Daunorubicin—hematologic cancer	7.25e-05	0.00133	CcSEcCtD
Difluprednate—Pruritus—Clofarabine—hematologic cancer	7.25e-05	0.00133	CcSEcCtD
Difluprednate—Pruritus—Pentostatin—hematologic cancer	7.22e-05	0.00133	CcSEcCtD
Difluprednate—Pruritus—Anagrelide—hematologic cancer	7.22e-05	0.00133	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	7.19e-05	0.00275	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	7.18e-05	0.00275	CbGpPWpGaD
Difluprednate—Vision blurred—Bortezomib—hematologic cancer	7.18e-05	0.00132	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	7.16e-05	0.00274	CbGpPWpGaD
Difluprednate—Halobetasol Propionate—NR3C1—hematologic cancer	7.16e-05	0.0441	CrCbGaD
Difluprednate—Lacrimation increased—Epirubicin—hematologic cancer	7.1e-05	0.00131	CcSEcCtD
Difluprednate—Herpes simplex—Epirubicin—hematologic cancer	7.1e-05	0.00131	CcSEcCtD
Difluprednate—Cortisone acetate—NR3C1—hematologic cancer	7.05e-05	0.0434	CrCbGaD
Difluprednate—Headache—Nelarabine—hematologic cancer	6.86e-05	0.00126	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	6.82e-05	0.00261	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	6.82e-05	0.00261	CbGpPWpGaD
Difluprednate—Megestrol acetate—NR3C1—hematologic cancer	6.79e-05	0.0418	CrCbGaD
Difluprednate—Pruritus—Teniposide—hematologic cancer	6.77e-05	0.00125	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	6.75e-05	0.00258	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—GATA3—hematologic cancer	6.74e-05	0.00258	CbGpPWpGaD
Difluprednate—Headache—Methoxsalen—hematologic cancer	6.7e-05	0.00123	CcSEcCtD
Difluprednate—Vision blurred—Thiotepa—hematologic cancer	6.69e-05	0.00123	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	6.68e-05	0.00256	CbGpPWpGaD
Difluprednate—Amcinonide—NR3C1—hematologic cancer	6.65e-05	0.041	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	6.65e-05	0.00254	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	6.59e-05	0.00252	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	6.58e-05	0.00252	CbGpPWpGaD
Difluprednate—Weight increased—Prednisolone—hematologic cancer	6.57e-05	0.00121	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—CREB1—hematologic cancer	6.57e-05	0.00251	CbGpPWpGaD
Difluprednate—Herpes simplex—Doxorubicin—hematologic cancer	6.57e-05	0.00121	CcSEcCtD
Difluprednate—Lacrimation increased—Doxorubicin—hematologic cancer	6.57e-05	0.00121	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	6.57e-05	0.00251	CbGpPWpGaD
Difluprednate—Fluticasone furoate—NR3C1—hematologic cancer	6.53e-05	0.0402	CrCbGaD
Difluprednate—Vision blurred—Thalidomide—hematologic cancer	6.48e-05	0.00119	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	6.45e-05	0.00247	CbGpPWpGaD
Difluprednate—Headache—Clofarabine—hematologic cancer	6.42e-05	0.00118	CcSEcCtD
Difluprednate—Headache—Daunorubicin—hematologic cancer	6.42e-05	0.00118	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—CREBBP—hematologic cancer	6.4e-05	0.00245	CbGpPWpGaD
Difluprednate—Headache—Pentostatin—hematologic cancer	6.39e-05	0.00118	CcSEcCtD
Difluprednate—Headache—Anagrelide—hematologic cancer	6.39e-05	0.00118	CcSEcCtD
Difluprednate—Mometasone—NR3C1—hematologic cancer	6.33e-05	0.039	CrCbGaD
Difluprednate—Pruritus—Busulfan—hematologic cancer	6.28e-05	0.00115	CcSEcCtD
Difluprednate—Rimexolone—NR3C1—hematologic cancer	6.26e-05	0.0385	CrCbGaD
Difluprednate—Vision blurred—Carmustine—hematologic cancer	6.22e-05	0.00114	CcSEcCtD
Difluprednate—Headache—Idarubicin—hematologic cancer	6.17e-05	0.00113	CcSEcCtD
Difluprednate—Vision blurred—Alitretinoin—hematologic cancer	6.16e-05	0.00113	CcSEcCtD
Difluprednate—Pruritus—Procarbazine—hematologic cancer	6.09e-05	0.00112	CcSEcCtD
Difluprednate—Vision blurred—Ifosfamide—hematologic cancer	6.09e-05	0.00112	CcSEcCtD
Difluprednate—Weight increased—Triamcinolone—hematologic cancer	6.05e-05	0.00111	CcSEcCtD
Difluprednate—Dry eye—Epirubicin—hematologic cancer	6.04e-05	0.00111	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	6.02e-05	0.0023	CbGpPWpGaD
Difluprednate—Headache—Teniposide—hematologic cancer	6e-05	0.0011	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	5.98e-05	0.00229	CbGpPWpGaD
Difluprednate—Pruritus—Bexarotene—hematologic cancer	5.97e-05	0.0011	CcSEcCtD
Difluprednate—Pruritus—Dasatinib—hematologic cancer	5.97e-05	0.0011	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	5.96e-05	0.00228	CbGpPWpGaD
Difluprednate—Pruritus—Fludarabine—hematologic cancer	5.95e-05	0.00109	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	5.94e-05	0.00227	CbGpPWpGaD
Difluprednate—Fluocinonide—NR3C1—hematologic cancer	5.9e-05	0.0363	CrCbGaD
Difluprednate—Beclomethasone—NR3C1—hematologic cancer	5.9e-05	0.0363	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	5.82e-05	0.00223	CbGpPWpGaD
Difluprednate—Vision blurred—Mitoxantrone—hematologic cancer	5.78e-05	0.00106	CcSEcCtD
Difluprednate—Fluocinolone Acetonide—NR3C1—hematologic cancer	5.74e-05	0.0353	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	5.69e-05	0.00218	CbGpPWpGaD
Difluprednate—Pruritus—Chlorambucil—hematologic cancer	5.64e-05	0.00104	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	5.6e-05	0.00214	CbGpPWpGaD
Difluprednate—Dry eye—Doxorubicin—hematologic cancer	5.59e-05	0.00103	CcSEcCtD
Difluprednate—Clobetasol propionate—NR3C1—hematologic cancer	5.58e-05	0.0344	CrCbGaD
Difluprednate—Flunisolide—NR3C1—hematologic cancer	5.58e-05	0.0344	CrCbGaD
Difluprednate—Headache—Busulfan—hematologic cancer	5.56e-05	0.00102	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—STAT1—hematologic cancer	5.53e-05	0.00211	CbGpPWpGaD
Difluprednate—Pruritus—Nilotinib—hematologic cancer	5.52e-05	0.00101	CcSEcCtD
Difluprednate—Paramethasone—NR3C1—hematologic cancer	5.51e-05	0.034	CrCbGaD
Difluprednate—Weight increased—Betamethasone—hematologic cancer	5.49e-05	0.00101	CcSEcCtD
Difluprednate—Weight increased—Dexamethasone—hematologic cancer	5.49e-05	0.00101	CcSEcCtD
Difluprednate—Pruritus—Imatinib—hematologic cancer	5.48e-05	0.00101	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	5.43e-05	0.00208	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	5.42e-05	0.00207	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	5.41e-05	0.00207	CbGpPWpGaD
Difluprednate—Headache—Procarbazine—hematologic cancer	5.39e-05	0.000991	CcSEcCtD
Difluprednate—Pruritus—Cladribine—hematologic cancer	5.39e-05	0.000991	CcSEcCtD
Difluprednate—Fluorometholone—NR3C1—hematologic cancer	5.38e-05	0.0331	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	5.38e-05	0.00206	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	5.36e-05	0.00205	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	5.3e-05	0.00203	CbGpPWpGaD
Difluprednate—Headache—Dasatinib—hematologic cancer	5.29e-05	0.000972	CcSEcCtD
Difluprednate—Headache—Bexarotene—hematologic cancer	5.29e-05	0.000972	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—ZNF552—hematologic cancer	5.28e-05	0.00202	CbGpPWpGaD
Difluprednate—Headache—Fludarabine—hematologic cancer	5.27e-05	0.000969	CcSEcCtD
Difluprednate—Eye pain—Epirubicin—hematologic cancer	5.26e-05	0.000967	CcSEcCtD
Difluprednate—Vision blurred—Cisplatin—hematologic cancer	5.25e-05	0.000965	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	5.22e-05	0.002	CbGpPWpGaD
Difluprednate—Methylprednisolone—NR3C1—hematologic cancer	5.2e-05	0.032	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—STAT5A—hematologic cancer	4.97e-05	0.0019	CbGpPWpGaD
Difluprednate—Pruritus—Melphalan—hematologic cancer	4.92e-05	0.000904	CcSEcCtD
Difluprednate—Headache—Nilotinib—hematologic cancer	4.88e-05	0.000898	CcSEcCtD
Difluprednate—Eye pain—Doxorubicin—hematologic cancer	4.87e-05	0.000895	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	4.87e-05	0.00186	CbGpPWpGaD
Difluprednate—Headache—Imatinib—hematologic cancer	4.86e-05	0.000893	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	4.83e-05	0.00185	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	4.82e-05	0.00184	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	4.78e-05	0.00183	CbGpPWpGaD
Difluprednate—Pruritus—Lenalidomide—hematologic cancer	4.78e-05	0.000879	CcSEcCtD
Difluprednate—Weight increased—Prednisone—hematologic cancer	4.78e-05	0.000878	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	4.77e-05	0.00183	CbGpPWpGaD
Difluprednate—Headache—Cladribine—hematologic cancer	4.77e-05	0.000877	CcSEcCtD
Difluprednate—Vision blurred—Prednisolone—hematologic cancer	4.74e-05	0.000872	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	4.7e-05	0.0018	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—NCOR1—hematologic cancer	4.67e-05	0.00179	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	4.65e-05	0.00178	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	4.62e-05	0.00177	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	4.62e-05	0.00177	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	4.61e-05	0.00176	CbGpPWpGaD
Difluprednate—Headache—Vinblastine—hematologic cancer	4.58e-05	0.000841	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—FOXO1—hematologic cancer	4.55e-05	0.00174	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	4.51e-05	0.00172	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	4.49e-05	0.00172	CbGpPWpGaD
Difluprednate—Pruritus—Bortezomib—hematologic cancer	4.4e-05	0.000809	CcSEcCtD
Difluprednate—Triamcinolone—NR3C1—hematologic cancer	4.39e-05	0.027	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	4.37e-05	0.00167	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	4.37e-05	0.00167	CbGpPWpGaD
Difluprednate—Pruritus—Bleomycin—hematologic cancer	4.37e-05	0.000802	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—EP300—hematologic cancer	4.36e-05	0.00167	CbGpPWpGaD
Difluprednate—Pruritus—Vinorelbine—hematologic cancer	4.29e-05	0.000789	CcSEcCtD
Difluprednate—Headache—Lenalidomide—hematologic cancer	4.23e-05	0.000778	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—FAS—hematologic cancer	4.19e-05	0.0016	CbGpPWpGaD
Difluprednate—Headache—Hydroxyurea—hematologic cancer	4.17e-05	0.000767	CcSEcCtD
Difluprednate—Pruritus—Thiotepa—hematologic cancer	4.1e-05	0.000754	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	4.09e-05	0.00157	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	4.06e-05	0.00155	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	4.06e-05	0.00155	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	4.04e-05	0.00154	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	4e-05	0.00153	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—CASC3—hematologic cancer	4e-05	0.00153	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	3.97e-05	0.00152	CbGpPWpGaD
Difluprednate—Pruritus—Thalidomide—hematologic cancer	3.97e-05	0.000729	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	3.95e-05	0.00151	CbGpPWpGaD
Difluprednate—Fluticasone Propionate—NR3C1—hematologic cancer	3.92e-05	0.0242	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	3.9e-05	0.00149	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	3.9e-05	0.00149	CbGpPWpGaD
Difluprednate—Headache—Bortezomib—hematologic cancer	3.89e-05	0.000716	CcSEcCtD
Difluprednate—Headache—Vinorelbine—hematologic cancer	3.8e-05	0.000699	CcSEcCtD
Difluprednate—Pruritus—Alitretinoin—hematologic cancer	3.77e-05	0.000694	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	3.77e-05	0.00144	CbGpPWpGaD
Difluprednate—Weight increased—Epirubicin—hematologic cancer	3.74e-05	0.000687	CcSEcCtD
Difluprednate—Pruritus—Ifosfamide—hematologic cancer	3.73e-05	0.000686	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	3.67e-05	0.0014	CbGpPWpGaD
Difluprednate—Headache—Thiotepa—hematologic cancer	3.63e-05	0.000668	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	3.59e-05	0.00138	CbGpPWpGaD
Difluprednate—Betamethasone—NR3C1—hematologic cancer	3.59e-05	0.0221	CrCbGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	3.53e-05	0.00135	CbGpPWpGaD
Difluprednate—Headache—Thalidomide—hematologic cancer	3.51e-05	0.000646	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	3.47e-05	0.00133	CbGpPWpGaD
Difluprednate—Weight increased—Doxorubicin—hematologic cancer	3.46e-05	0.000635	CcSEcCtD
Difluprednate—Pruritus—Gemcitabine—hematologic cancer	3.45e-05	0.000634	CcSEcCtD
Difluprednate—Vision blurred—Prednisone—hematologic cancer	3.45e-05	0.000634	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	3.43e-05	0.00131	CbGpPWpGaD
Difluprednate—Headache—Carmustine—hematologic cancer	3.37e-05	0.00062	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	3.36e-05	0.00129	CbGpPWpGaD
Difluprednate—Headache—Alitretinoin—hematologic cancer	3.34e-05	0.000614	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	3.33e-05	0.00127	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—CREB1—hematologic cancer	3.3e-05	0.00126	CbGpPWpGaD
Difluprednate—Megestrol acetate—ABCB1—hematologic cancer	3.28e-05	0.0202	CrCbGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	3.25e-05	0.00124	CbGpPWpGaD
Difluprednate—Headache—Vincristine—hematologic cancer	3.22e-05	0.000592	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—RB1—hematologic cancer	3.2e-05	0.00123	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	3.2e-05	0.00122	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	3.2e-05	0.00122	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	3.17e-05	0.00121	CbGpPWpGaD
Difluprednate—Fluticasone furoate—ABCB1—hematologic cancer	3.15e-05	0.0194	CrCbGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	3.15e-05	0.0012	CbGpPWpGaD
Difluprednate—Headache—Irinotecan—hematologic cancer	3.14e-05	0.000577	CcSEcCtD
Difluprednate—Headache—Mitoxantrone—hematologic cancer	3.14e-05	0.000577	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	3.13e-05	0.0012	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	3.12e-05	0.0012	CbGpPWpGaD
Difluprednate—Headache—Gemcitabine—hematologic cancer	3.06e-05	0.000562	CcSEcCtD
Difluprednate—Pruritus—Etoposide—hematologic cancer	2.95e-05	0.000542	CcSEcCtD
Difluprednate—Vision blurred—Methotrexate—hematologic cancer	2.88e-05	0.000529	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	2.85e-05	0.00109	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	2.84e-05	0.00109	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	2.79e-05	0.00107	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	2.78e-05	0.00107	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	2.78e-05	0.00106	CbGpPWpGaD
Difluprednate—Vision blurred—Epirubicin—hematologic cancer	2.7e-05	0.000495	CcSEcCtD
Difluprednate—Pruritus—Triamcinolone—hematologic cancer	2.67e-05	0.000491	CcSEcCtD
Difluprednate—Headache—Etoposide—hematologic cancer	2.61e-05	0.00048	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—RARS—hematologic cancer	2.58e-05	0.000987	CbGpPWpGaD
Difluprednate—Headache—Prednisolone—hematologic cancer	2.57e-05	0.000473	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	2.57e-05	0.000984	CbGpPWpGaD
Difluprednate—Methylprednisolone—ABCB1—hematologic cancer	2.51e-05	0.0155	CrCbGaD
Difluprednate—Vision blurred—Doxorubicin—hematologic cancer	2.49e-05	0.000458	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—POLR3E—hematologic cancer	2.43e-05	0.000928	CbGpPWpGaD
Difluprednate—Pruritus—Betamethasone—hematologic cancer	2.42e-05	0.000446	CcSEcCtD
Difluprednate—Pruritus—Dexamethasone—hematologic cancer	2.42e-05	0.000446	CcSEcCtD
Difluprednate—Dexamethasone—ABCG2—hematologic cancer	2.42e-05	0.0149	CrCbGaD
Difluprednate—Headache—Triamcinolone—hematologic cancer	2.37e-05	0.000435	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	2.35e-05	0.000901	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	2.33e-05	0.000893	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	2.3e-05	0.000881	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	2.27e-05	0.000867	CbGpPWpGaD
Difluprednate—Headache—Dexamethasone—hematologic cancer	2.15e-05	0.000395	CcSEcCtD
Difluprednate—Headache—Betamethasone—hematologic cancer	2.15e-05	0.000395	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	2.12e-05	0.00081	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	2.11e-05	0.000808	CbGpPWpGaD
Difluprednate—Pruritus—Prednisone—hematologic cancer	2.11e-05	0.000388	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—TET2—hematologic cancer	2.1e-05	0.000805	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RARA—hematologic cancer	2.1e-05	0.000805	CbGpPWpGaD
Difluprednate—Dexamethasone—NR3C1—hematologic cancer	2.09e-05	0.0129	CrCbGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	2.07e-05	0.000794	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPLP1—hematologic cancer	2.06e-05	0.000789	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—STAT3—hematologic cancer	2.05e-05	0.000786	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	2.05e-05	0.000785	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NR0B2—hematologic cancer	1.96e-05	0.000748	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	1.95e-05	0.000747	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1.93e-05	0.000739	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	1.91e-05	0.000732	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TGFB1—hematologic cancer	1.9e-05	0.000728	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	1.89e-05	0.000724	CbGpPWpGaD
Difluprednate—Headache—Prednisone—hematologic cancer	1.87e-05	0.000344	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—DNMT3A—hematologic cancer	1.87e-05	0.000714	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ELL—hematologic cancer	1.84e-05	0.000703	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.8e-05	0.000688	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	1.79e-05	0.000686	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TNF—hematologic cancer	1.78e-05	0.00068	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NCOR2—hematologic cancer	1.77e-05	0.000675	CbGpPWpGaD
Difluprednate—Pruritus—Methotrexate—hematologic cancer	1.76e-05	0.000324	CcSEcCtD
Difluprednate—Betamethasone—ABCB1—hematologic cancer	1.73e-05	0.0107	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	1.71e-05	0.000653	CbGpPWpGaD
Difluprednate—Pruritus—Epirubicin—hematologic cancer	1.65e-05	0.000304	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—AGO2—hematologic cancer	1.63e-05	0.000623	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—DNMT3B—hematologic cancer	1.59e-05	0.00061	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—H3F3B—hematologic cancer	1.59e-05	0.00061	CbGpPWpGaD
Difluprednate—Headache—Methotrexate—hematologic cancer	1.56e-05	0.000287	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	1.54e-05	0.000588	CbGpPWpGaD
Difluprednate—Pruritus—Doxorubicin—hematologic cancer	1.53e-05	0.000281	CcSEcCtD
Difluprednate—Headache—Epirubicin—hematologic cancer	1.46e-05	0.000269	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—RPS14—hematologic cancer	1.46e-05	0.000558	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NUP98—hematologic cancer	1.44e-05	0.000549	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IL6—hematologic cancer	1.43e-05	0.000549	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NUP214—hematologic cancer	1.38e-05	0.000529	CbGpPWpGaD
Difluprednate—Headache—Doxorubicin—hematologic cancer	1.35e-05	0.000249	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	1.34e-05	0.000513	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	1.3e-05	0.000496	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	1.27e-05	0.000488	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HSPB1—hematologic cancer	1.27e-05	0.000488	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.24e-05	0.000474	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SMC1A—hematologic cancer	1.22e-05	0.000467	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—H3F3A—hematologic cancer	1.2e-05	0.000458	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	1.17e-05	0.000449	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—EZH2—hematologic cancer	1.15e-05	0.000439	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PARP1—hematologic cancer	1.12e-05	0.00043	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HDAC2—hematologic cancer	1.08e-05	0.000415	CbGpPWpGaD
Difluprednate—Dexamethasone—ABCB1—hematologic cancer	1.01e-05	0.00621	CrCbGaD
Difluprednate—NR3C1—Gene Expression—AR—hematologic cancer	9.39e-06	0.000359	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—CDKN2B—hematologic cancer	8.66e-06	0.000331	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NCOR1—hematologic cancer	8.21e-06	0.000314	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	6.97e-06	0.000267	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MAPK14—hematologic cancer	6.58e-06	0.000252	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ESR1—hematologic cancer	6.45e-06	0.000247	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NOTCH1—hematologic cancer	6.24e-06	0.000239	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—CREBBP—hematologic cancer	5.65e-06	0.000216	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MAPK3—hematologic cancer	3.45e-06	0.000132	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MYC—hematologic cancer	3.36e-06	0.000128	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—AKT1—hematologic cancer	2.33e-06	8.9e-05	CbGpPWpGaD
